Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acute and Subacute Effect of Tadalafil Administration on Vasodilatation Mediated by Flow in Patients With Obesity Grade I-ii and Erectil Dysfunction

NCT03905018 is registered in ClinicalTrials.gov with Centro Universitario de Ciencias de la Salud, Mexico as lead sponsor.

NCT NCT03905018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03905018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acute and Subacute Effect of Tadalafil Administration on Vasodilatation Mediated by Flow in Patients With Obesity Grade I-ii and Erectil Dysfunction
Lead sponsor
Centro Universitario de Ciencias de la Salud, Mexico
Phase
Phase 3
Overall status
Unknown status
Start date
May 1, 2019
Completion date
September 1, 2019
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity and erectile dysfuntion